Edges in Network
| Network | GSE16391_egf1520 - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | VEGFB |
| Upstream (Parents) |
|---|
| (<<) BAD → VEGFB |
| (<<) GNA15 → VEGFB |
| (<<) HMGCS1 → VEGFB |
| (<<) HSP90AA1 → VEGFB |
| (<<) ICAM2 → VEGFB |
| (<<) IER3 → VEGFB |
| (<<) IGFBP6 → VEGFB |
| (<<) ILK → VEGFB |
| (<<) LRP5 → VEGFB |
| (<<) MAPK11 → VEGFB |
| (<<) MAPK6 → VEGFB |
| (<<) PKIG → VEGFB |
| (<<) SPDEF → VEGFB |
| (<<) TARS → VEGFB |
| (<<) TGFB1 → VEGFB |
| Downstream (Children) |
|---|
| VEGFB → ASNS (>>) |
| VEGFB → ATP2C2 (>>) |
| VEGFB → CDR2 (>>) |
| VEGFB → CEBPA (>>) |
| VEGFB → E2F3 (>>) |
| VEGFB → GPX1 (>>) |
| VEGFB → KRT16 (>>) |
| VEGFB → MTHFD2 (>>) |
| VEGFB → PRR5 (>>) |
